Ampio Financial Statements From 2010 to 2025
Ampio Pharm financial statements provide useful quarterly and yearly information to potential Ampio Pharm investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ampio Pharm financial statements helps investors assess Ampio Pharm's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ampio Pharm's valuation are summarized below:Ampio Pharm does not presently have any fundamental signals for analysis.
This module can also supplement various Ampio Pharm Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Check Ampio Pharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ampio Pharm's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ampio financial statements analysis is a perfect complement when working with Ampio Pharm Valuation or Volatility modules.
Ampio |
Ampio Pharm Company Shares Owned By Insiders Analysis
Ampio Pharm's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Ampio Pharm Shares Owned By Insiders | 1.56 % |
Most of Ampio Pharm's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ampio Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 1.561% of Ampio Pharm are shares owned by insiders. This is 89.72% lower than that of the Pharmaceuticals sector and 88.99% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 84.53% higher than that of the company.
Ampio Pharm Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ampio Pharm's current stock value. Our valuation model uses many indicators to compare Ampio Pharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ampio Pharm competition to find correlations between indicators driving Ampio Pharm's intrinsic value. More Info.Ampio Pharm is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ampio Pharm's earnings, one of the primary drivers of an investment's value.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |